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ANTIBIOTICS WITH PERCUTANEOUS ASPIRATION
OR DRAINAGE FOR PYOGENIC LIVER ABSCESS
ABSTRACT
Stain, S.C., Yellin, A.E., Donovan, A.J. and Brien, H.W. Pyogenic Liver Abscess.
Archives of Surgery, 126: 991-996.
Historically, open surgical drainage has been the treatment of choice for pyogenic
liver abscess. The records of 54 patients with pyogenic liver abscess were reviewed to
determine whether earlier diagnosis with current imaging tests and definitive
treatment with antibiotics, aspiration, or catheter drainage was an effective alterna-
tive to open drainage. Twenty-nine patients were treated with broad-spectrum
antibiotics and diagnostic aspiration. Twenty-three (79%) recovered uneventfully,
and six required catheter or operative drainage. Twenty-three patients (including
five who failed aspiration) underwent drainage with percutaneously placed cath-
eters. Nineteen (83%) recovered; four required open surgical drainage. Of seven
patients who required open surgical drainage, six recovered. One (2%) of the 54
patients died following failed aspiration and catheter and surgical drainage. Four
patients were successfully treated with antibiotics alone without aspiration. These
results confirm that pyogenic liver abscess can be successfully treated with broad-
spectrum antibiotics and aspiration or percutaneous catheter drainage. Open
surgical drainage is reserved for patients in whom treatment fails or who require
celiotomy for concurrent disease.
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The methods of diagnosis and treatment of pyogenic liver abscess have surely
undergone considerable changes in the past ten years.
As a matter of fact, advances in imaging techniques, including ultrasonography
and computed tomography, may provide a prompt diagnosis with an accuracy that
approaches 100%, ranging from 85 to 100% in the various series, and mortality
rates have decreased consistently from the early 77%-95%, as first reported by
Ochsner and De Bakey in 1938, to the current figures of 19.2% and 16%-18%
down to 11% 4.
Therapeutic options have changed likewise over the years, lessening the role for
surgical intervention in selected cases, with the majority of pyogenic liver abscesses
being nowadays treated by percutaneous drainage or needle aspiration. The paper
from Los Angeles by a group with published previous experience is a thorough
outline of the modern aspects concerning this disease starting from the microbiolo-
gic findings which reveal an ever increasing prevalence of polymicrobial and
anaerobic infections as a causative factor. This point is widely supported by recent
literature. The paper includes 29 patients. Needle aspiration and specific antibiotic
therapy, based upon the bacteriologic results, was employed for abscesses of
different size, varying from 2 to 15 cm in diameter: about 20% of these patients
required subsequent treatment, either percutaneous or surgical. They do not state
in which patients the primary treatment failed, what the size of the abscess was, the
condition of the patients before undergoing treatment, what the underlying disease
responsible for the liver abscess was and finally, in how many patients the hepatic
lesion was solitary.
Another point that I would like to focus upon is the cost-benefit ratio considering
that the duration of hospitalization for those patients ranged from six to forty-nine
days.
The therapeutic effective.hess of percutaneous drainage is well-known as well as
the complications and the length of hospitalization related to this procedure.
However, it is worthwhile to mention the experience reported by the group from
Duke University who described a recurrence rate of about 41% within 2 weeks
after percutaneous drainage of liver abscesses while it was only 19% when the
abscess was drained surgically.
The choice of surgical approach for the drainage of hepatic abscess has become
the major subject of controversy and surgery is commonly regarded as a secondary
treatment, as also emphasized in this article. The high mortality rate of up to 32%,
reported for open surgical drainage is likely due to the the fact that the patients
undergoing surgery usually have failed a previous percutaneous drainage or,
alternatively, require operation for concurrent abdominal disease.
On the other hand, the data reported from Duke University, showed a mortality
rate of 45% with antibiotic therapy alone, 25% following percutaneous drainage
and 9.5% following surgical drainage. These features are strikingly in contrast to
the data presented by the authors of this article.
It is difficult to compare the merits of different procedures mainly because the
data obtained usually refer to experiences that seldom overlap.
In my opinion the guidelines that have been suggested in this paper do not apply
to every patient with a liver abscess and a more individualized approach would
seem more appropriate.
I, therefore, believe that exploratory needle aspiration and subsequent antibiotic
therapy should be reserved for those patients with a single, small-sized abscess,HPB INTERNATIONAL 327
without underlying abdominal pathology. As far as percutaneous drainage is
concerned, it certainly is a reliable procedure by which pus and necrotic debris may
be removed and the abscess cavity washed. Nevertheless I do not believe that it will
be of any help in treating multiple, superficially located abscesses or in the
management of patients with severe sepsis and associated pathology such as in
acute suppurative cholangitis where the obstruction of the biliary tract results in
multiple abscesses scattered throughout both hepatic lobes and severe sepsis occurs
accounting for the high mortality rate.
The most correct therapeutic approach to pyogenic liver abscess requires an
accurate diagnostic work-up aimed at precisely defining size, location and the
number of lesions as well as the type of pathogens involved. In dealing with this
desease, one last point deserves to be mentioned, the basic rule from times long
past, which still holds good: Ubi pus ibi evacuat.
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PROPHYLACTIC SCLEROTHERAPY FOR
OESOPHAGEAL VARICES
ABSTRACT
The Veterans Affairs Cooperative Variceal Sclerotherapy Group. (1991)
Prophylactic sclerotherapy for esophageal varices in men with alcoholic liver
disease. The New England Journal of Medicine; 324: 1779-1784.
Background. Sclerotherapy is an effective treatment for bleeding esophageal varices
in patients with alcoholic liver disease. It has also been suggested that sclerotherapy
might be effective in preventing initial episodes of bleeding and improving survival
among such patients.